The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells

Overview of attention for article published in Cancers, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 1 X user

peer_reviews: 1 peer review site

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 1 X post from an account with 483 followers.

🆕@Cancers_MDPI: Acute myeloid leukemia (AML) cell were treated with HDAC inhibitor TMP269, to investigate the cellular consequences induced by HDAC inhibition, observing significant anti-proliferative effects & a potential as a therapeutic drug in AM…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.